Reagents and Controls with use of Sysmex XN9100-201 System w/ CellaVision DI-60

This is a Sources Sought Notice for Tripler Army Medical Center. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources and whether or not to conduct this procurement on a competitive basis. The NAICS code is 325413 and the successful vendor must be registered in SAM.gov with this NAICS.

Responses to the information requested will assist the Government in determining the appropriate set-aside and acquisition method. The Medical Readiness Contracting Office – Pacific intends to award a Firm, Fixed-Price order for a base period with up to four (4) option periods to the successful offeror using FAR Parts 8 and 12 procedures.

The requirement is for a firm fixed-price contract based on 9,886 tests per month (Cost Per Reportable Result – CPRR) that includes ALL Food and Drug Administration (FDA) approved reagents to provide the following:

fully automated and reportable complete blood count (CBC) with automated differential, nucleated red cell count; body fluid analysis capability (serous, synovial, and cerebrospinal fluid (CSF)) with white blood cell (WBC), red blood cell (RBC) and total nucleated cell counts to include a 2-part WBC differential with every body-fluid analysis; fully reportable reticulated hemoglobin quantification and immature reticulocyte parameters; fully reportable fluorescent platelet parameter to pair with system’s impedance platelet (PLT) technology; fully reportable extended platelet parameters for the determination of thrombopoiesis to aid in the determination platelet engagement, as well as chemotherapy decisions; and immature granulocyte parameter.

The requirement will include the use of the Sysmex XN9100-201 fully automated hematology system with XN10 CBC analyzers, SP-50 Automatic Slide Maker/Stainer, RU-20 reagent dilution unit, CellaVision DI-60 digital slide reader, and BT-50 QC Terminal. Also, provide on-site calibration, maintenance and service calls, and quality control (QC). Interested vendors may submit in writing their capabilities and qualifications demonstrating their ability to fulfill the requirement identified in this notice.

Responses to this notice should include company name, address, and telephone number, point of contact (POC), and brochures which will allow the Government to understand your offerings and options. Capability statements should be submitted to the attention of Ms. Megumi Kuwada, Contract Specialist, email megumi.kuwada.civ@health.mil. Telephone responses will not be accepted. Responses must be received no later than 14 June 2024 at 10:00 AM Hawaii Standard Time.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required items.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response. A determination by the government not to compete this proposed effort on a full and open competition basis, based upon responses to this notice, is solely within the discretion of the government.